Montag & Associates’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$22M Buy
90,103
+2,041
+2% +$475K 1.02% 23
2025
Q4
$18.2M Buy
88,062
+3,242
+4% +$641K 0.83% 28
2025
Q3
$15.7M Sell
84,820
-3,407
-4% -$584K 0.72% 33
2025
Q2
$13.5M Sell
88,227
-6,633
-7% -$1.02M 0.66% 39
2025
Q1
$15.7M Sell
94,860
-3,130
-3% -$490K 0.79% 31
2024
Q4
$14.2M Sell
97,990
-9,563
-9% -$1.48M 0.67% 37
2024
Q3
$17.4M Buy
107,553
+241
+0.2% +$38.4K 0.82% 28
2024
Q2
$15.7M Sell
107,312
-2,057
-2% -$306K 0.79% 32
2024
Q1
$17.3M Sell
109,369
-5,315
-5% -$846K 0.86% 25
2023
Q4
$18M Sell
114,684
-2,162
-2% -$332K 1% 22
2023
Q3
$18.2M Sell
116,846
-3,829
-3% -$632K 1.15% 15
2023
Q2
$20M Buy
120,675
+3,222
+3% +$520K 1.23% 14
2023
Q1
$18.2M Sell
117,453
-461
-0.4% -$74.4K 1.19% 14
2022
Q4
$20.8M Sell
117,914
-1,526
-1% -$263K 1.39% 12
2022
Q3
$19.5M Buy
119,440
+1,972
+2% +$334K 1.35% 14
2022
Q2
$20.9M Sell
117,468
-1,421
-1% -$253K 1.35% 13
2022
Q1
$21.1M Buy
118,889
+829
+0.7% +$141K 1.12% 13
2021
Q4
$20.2M Sell
118,060
-854
-0.7% -$140K 1% 17
2021
Q3
$19.2M Buy
118,914
+4,304
+4% +$734K 1.03% 18
2021
Q2
$18.9M Sell
114,610
-343
-0.3% -$56.8K 1% 19
2021
Q1
$18.9M Sell
114,953
-504
-0.4% -$81.6K 1.06% 16
2020
Q4
$18.2M Buy
115,457
+3,074
+3% +$454K 1.12% 14
2020
Q3
$16.7M Sell
112,383
-2,753
-2% -$407K 1.35% 12
2020
Q2
$16.2M Buy
115,136
+1,937
+2% +$282K 1.42% 12
2020
Q1
$14.8M Sell
113,199
-9,638
-8% -$1.37M 1.48% 12
2019
Q4
$17.9M Sell
122,837
-5,229
-4% -$709K 1.43% 13
2019
Q3
$16.6M Sell
128,066
-7,004
-5% -$923K 1.44% 12
2019
Q2
$18.8M Sell
135,070
-29,545
-18% -$4.09M 1.68% 8
2019
Q1
$23M Sell
164,615
-19,398
-11% -$2.6M 2.13% 5
2018
Q4
$23.7M Sell
184,013
-36,800
-17% -$5.13M 2.55% 5
2018
Q3
$30.5M Buy
220,813
+118,108
+115% +$15.7M 2.67% 4
2018
Q2
$12.5M Sell
102,705
-2,112
-2% -$263K 1.28% 10
2018
Q1
$13.4M Buy
104,817
+383
+0.4% +$51.8K 1.38% 6
2017
Q4
$14.6M Buy
104,434
+385
+0.4% +$53.6K 1.41% 8
2017
Q3
$13.5M Sell
104,049
-1,165
-1% -$154K 1.45% 7
2017
Q2
$13.9M Buy
105,214
+1,696
+2% +$216K 1.56% 6
2017
Q1
$12.9M Sell
103,518
-770
-0.7% -$92K 1.44% 7
2016
Q4
$12M Sell
104,288
-1,734
-2% -$200K 1.42% 10
2016
Q3
$12.5M Sell
106,022
-439
-0.4% -$53.3K 1.59% 5
2016
Q2
$12.9M Sell
106,461
-632
-0.6% -$71.8K 1.71% 7
2016
Q1
$11.6M Buy
107,093
+2,810
+3% +$291K 1.63% 9
2015
Q4
$10.7M Sell
104,283
-1,095
-1% -$110K 1.57% 11
2015
Q3
$9.84M Sell
105,378
-5,022
-5% -$486K 1.54% 11
2015
Q2
$10.8M Sell
110,400
-6,931
-6% -$694K 1.57% 9
2015
Q1
$11.8M Sell
117,331
-251
-0.2% -$25.5K 1.71% 7
2014
Q4
$12.3M Buy
117,582
+11,943
+11% +$1.26M 1.85% 6
2014
Q3
$11.3M Buy
105,639
+20,189
+24% +$2.09M 1.86% 6
2014
Q2
$8.94M Buy
85,450
+205
+0.2% +$20.7K 1.46% 9
2014
Q1
$8.37M Sell
85,245
-5,595
-6% -$519K 1.42% 11
2013
Q4
$8.32M Buy
90,840
+1,438
+2% +$133K 1.43% 10
2013
Q3
$7.75M Buy
89,402
+1,661
+2% +$149K 1.45% 13
2013
Q2
$7.53M Buy
+87,741
New +$7.45M 1.54% 7

Other funds holding JNJ

Montag & Associates's JNJ Position: Q1 2026 in Review

Montag & Associates increased its Johnson & Johnson (JNJ) stake by 2.3% in Q1 2026, buying an estimated $475K and bringing the position to 90,103 shares worth $22M. The position accounts for 1.02% of the portfolio, ranked #23.

Montag & Associates first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $30.5M in Q3 2018. 4,616 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Montag & Associates held 90,103 shares of Johnson & Johnson worth $22M as of Q1 2026.
  • Montag & Associates bought 2,041 Johnson & Johnson shares in Q1 2026, an estimated $475K.
  • Johnson & Johnson made up 1.02% of Montag & Associates's portfolio in Q1 2026, its #23 holding.
  • Montag & Associates first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Montag & Associates's Johnson & Johnson position peaked at $30.5M in Q3 2018.
  • 4,616 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Montag & Associates's 13F filing for Q1 2026, filed 29 Apr 2026.